FI965074A0 - Tropaani-2-aldoksiinijohdannaisia hermoston välittäjäaineiden takaisinoton estäjinä - Google Patents

Tropaani-2-aldoksiinijohdannaisia hermoston välittäjäaineiden takaisinoton estäjinä

Info

Publication number
FI965074A0
FI965074A0 FI965074A FI965074A FI965074A0 FI 965074 A0 FI965074 A0 FI 965074A0 FI 965074 A FI965074 A FI 965074A FI 965074 A FI965074 A FI 965074A FI 965074 A0 FI965074 A0 FI 965074A0
Authority
FI
Finland
Prior art keywords
pct
neurotransmitter
reuptake
inhibitors
aldoxine
Prior art date
Application number
FI965074A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI965074A7 (fi
Inventor
Peter Moldt
Frank Watjen
Jorgen Scheel-Krueger
Original Assignee
Neurosearch As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch As filed Critical Neurosearch As
Publication of FI965074A0 publication Critical patent/FI965074A0/fi
Publication of FI965074A7 publication Critical patent/FI965074A7/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Addiction (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
FI965074A 1994-04-19 1996-12-17 Tropaani-2-aldoksiinijohdannaisia hermoston välittäjäaineiden takaisinoton estäjinä FI965074A7 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK44794 1994-04-19
DK133894 1994-11-24
PCT/EP1995/001358 WO1995028401A1 (en) 1994-04-19 1995-04-12 Tropane-2-aldoxine derivatives as neurotransmitter reuptake inhibitors

Publications (2)

Publication Number Publication Date
FI965074A0 true FI965074A0 (fi) 1996-12-17
FI965074A7 FI965074A7 (fi) 1996-12-17

Family

ID=26064021

Family Applications (1)

Application Number Title Priority Date Filing Date
FI965074A FI965074A7 (fi) 1994-04-19 1996-12-17 Tropaani-2-aldoksiinijohdannaisia hermoston välittäjäaineiden takaisinoton estäjinä

Country Status (25)

Country Link
US (1) US5736556A (cs)
EP (1) EP0756596B1 (cs)
JP (1) JP2899418B2 (cs)
KR (1) KR100210417B1 (cs)
CN (1) CN1043763C (cs)
AT (1) ATE222587T1 (cs)
AU (1) AU690257B2 (cs)
BG (1) BG63259B1 (cs)
BR (1) BR9507489A (cs)
CA (1) CA2187309C (cs)
CZ (1) CZ284379B6 (cs)
DE (1) DE69527839T2 (cs)
DK (1) DK0756596T3 (cs)
EE (1) EE03877B1 (cs)
FI (1) FI965074A7 (cs)
GE (1) GEP19991749B (cs)
HU (1) HU215830B (cs)
LV (1) LV11738B (cs)
NO (1) NO964180L (cs)
NZ (1) NZ284075A (cs)
PL (1) PL183025B1 (cs)
RU (1) RU2134264C1 (cs)
SK (1) SK280875B6 (cs)
UA (1) UA49801C2 (cs)
WO (1) WO1995028401A1 (cs)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0859777B1 (en) * 1995-10-13 2007-05-23 Neurosearch A/S 8-azabicyclo(3.2.1)oct-2-ene derivatives, their preparation and use
US6241963B1 (en) * 1995-10-19 2001-06-05 The Trustees Of The University Of Pennsylvania Dopamine and serotonin transporter ligands and imaging agents
KR100277482B1 (ko) * 1995-11-02 2001-01-15 페더 벨링 신경전달물질 재흡수 저해제인 융합구조의 트로판 유도체
US5948933A (en) * 1997-07-11 1999-09-07 Organix, Inc. Tropane analogs and methods for inhibition of monoamine transport
CN1077574C (zh) * 1996-02-22 2002-01-09 神经研究公司 托烷衍生物,其制备和应用
US6232326B1 (en) 1998-07-14 2001-05-15 Jodi A. Nelson Treatment for schizophrenia and other dopamine system dysfunctions
CA2416233A1 (en) 1999-07-13 2001-01-18 Alpha Research Group, Llc Compositions and methods for the treatment of parkinson's disease
US20040229908A1 (en) * 1999-07-13 2004-11-18 Jodi Nelson Compositions and methods for the treatment of Parkinson's disease and tardive dyskinesias
US6667314B2 (en) 2000-05-26 2003-12-23 Pfizer, Inc. Tropane derivatives useful in therapy
OA12264A (en) * 2000-05-26 2003-11-10 Pfizer Tryasolyl tropane derivatives as CCR5 modulators.
WO2002102801A1 (en) * 2001-05-23 2002-12-27 Neurosearch A/S Tropane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
US6610849B2 (en) * 2001-06-28 2003-08-26 Boehringer Ingelheim Pharma Kg Process for the manufacture of tropenol
US7381733B2 (en) 2001-11-30 2008-06-03 Neurosearch A/S Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases
DE10200943A1 (de) * 2002-01-12 2003-07-24 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Scopinestern
US7476740B2 (en) * 2002-03-28 2009-01-13 President And Fellows Of Harvard College Tropane compounds
RS20060198A (sr) 2003-10-03 2008-09-29 Pfizer Limited, Derivati tropana supstituisani sa imidazopiridinom koji deluju kao antagonisti ccr5 receptora za tretman hiv-a i inflamacije
JP2007508336A (ja) * 2003-10-16 2007-04-05 ニューロサーチ、アクティーゼルスカブ モノアミン神経伝達物質再取り込みインヒビター及びアセチルコリンエステラーゼインヒビターを含む医薬組成物
WO2005070429A1 (en) * 2004-01-22 2005-08-04 Neurosearch A/S Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an n-methyl-d-aspartate (nmda) receptors antagonist
AU2005205880B2 (en) * 2004-01-22 2010-06-10 Neurosearch A/S Compounds for the sustained reduction of body weight
RU2352332C1 (ru) * 2005-01-14 2009-04-20 Частное Предприятие "Славянская Клиника" Применение местного анестетика для коррекции пищевого поведения человека и способ применения
EP1779851A1 (en) 2005-10-31 2007-05-02 Boehringer Ingelheim Pharma GmbH & Co.KG Treatment of diabetes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3813404A (en) * 1972-11-15 1974-05-28 Sterling Drug Inc Tropane-2-carboxylates and derivatives
SU941369A1 (ru) * 1978-12-29 1982-07-07 Научно-исследовательский институт фармакологии АМН СССР Хлоргидраты W-аминоацильных эфиров тропан-3-ола как стимул торы центральной нервной системы
AT397962B (de) * 1985-12-27 1994-08-25 Madaus & Co Dr Verfahren zur herstellung von azoniaspironortropanolestern
AU671163B2 (en) * 1992-12-23 1996-08-15 Neurosearch A/S Alkyl substituted heterocyclic compounds
AU672052B2 (en) * 1992-12-23 1996-09-19 Neurosearch A/S Antidepressant and antiparkinsonian compounds

Also Published As

Publication number Publication date
BG63259B1 (bg) 2001-07-31
CZ298296A3 (en) 1997-06-11
CA2187309C (en) 2000-11-21
GEP19991749B (en) 1999-09-10
EP0756596B1 (en) 2002-08-21
PL183025B1 (pl) 2002-05-31
SK280875B6 (sk) 2000-08-14
UA49801C2 (uk) 2002-10-15
DK0756596T3 (da) 2002-12-23
FI965074A7 (fi) 1996-12-17
CA2187309A1 (en) 1995-10-26
CZ284379B6 (cs) 1998-11-11
SK128896A3 (en) 1997-04-09
RU2134264C1 (ru) 1999-08-10
US5736556A (en) 1998-04-07
EE9600132A (et) 1997-04-15
PL316876A1 (en) 1997-02-17
BG100883A (en) 1998-03-31
CN1043763C (zh) 1999-06-23
EE03877B1 (et) 2002-10-15
KR100210417B1 (ko) 1999-07-15
WO1995028401A1 (en) 1995-10-26
DE69527839D1 (en) 2002-09-26
NO964180L (no) 1996-12-16
JPH09505607A (ja) 1997-06-03
JP2899418B2 (ja) 1999-06-02
BR9507489A (pt) 1997-08-12
LV11738B (en) 1997-12-20
NO964180D0 (no) 1996-10-02
AU2257595A (en) 1995-11-10
HUT75865A (en) 1997-05-28
LV11738A (lv) 1997-04-20
AU690257B2 (en) 1998-04-23
HU215830B (hu) 2001-05-28
ATE222587T1 (de) 2002-09-15
DE69527839T2 (de) 2003-01-02
EP0756596A1 (en) 1997-02-05
NZ284075A (en) 1998-01-26
MX9604966A (es) 1998-05-31
CN1148854A (zh) 1997-04-30
HU9602707D0 (en) 1996-11-28

Similar Documents

Publication Publication Date Title
FI965074A0 (fi) Tropaani-2-aldoksiinijohdannaisia hermoston välittäjäaineiden takaisinoton estäjinä
BR9610960A (pt) Derivados de 8-azabiciclo [3.2.1] oct -2- eno sua preparação e uso
IL110494A0 (en) Perhydroisoindole derivatives, their preparation and pharmaceutical compositions which contain them
CA2244773A1 (en) Tropane-derivatives, their preparation and use
IL151172A0 (en) Amine derivatives, their preparation and use as bax modulators
DE69313051D1 (de) Ethanolamin-derivate mit sympathomimetischer und anti-pollakiuria wirkung
FI964340A0 (fi) Uudet asykliset ja sykliset amidit hermoston välittäjäaineen vapautumisen tehostimina
DE69525327D1 (de) Anthracyclin-derivate
CA2112061A1 (en) Alkyl substituted heterocyclic compounds
BR9607841A (pt) Método para a preparação de estéres de anidroeggonina

Legal Events

Date Code Title Description
NF Re-establishment of lapsed right